Logo.jpg
ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
January 05, 2023 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it...
Logo.jpg
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
December 19, 2022 08:30 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. “ProPhase” (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that it...
Logo.jpg
ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
November 30, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that it will be...
Logo.jpg
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
November 10, 2022 08:00 ET | ProPhase Labs, Inc.
Q3 2022 Net Revenues of $24.2 Million (a Q3 record); Up 155% Year-over-Year Q3 2022 Net Income of $1.0 Million versus a loss in Q3 2021 Q3 2022 adjusted EBITDA of $6.3 million (a Q3...
Logo.jpg
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
November 08, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Logo.jpg
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
November 07, 2022 19:12 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time
November 04, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
Logo.jpg
ProPhase Labs Announces Collaboration with G42 Healthcare
October 19, 2022 08:00 ET | ProPhase Labs, Inc.
Companies target emerging markets across the globe and joint venture opportunitiesProPhase and G42 Healthcare to explore creation of advanced genomic sequencing facility in the USCompanies enter...
Logo.jpg
ProPhase Labs to Present at The ThinkEquity Conference
October 18, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
October 17, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...